These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11736917)

  • 61. Terbinafine induced pityriasis rosea-like eruption.
    George A; Bhatia A; Kanish B; Williams A
    Indian J Pharmacol; 2015; 47(6):680-1. PubMed ID: 26729964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent.
    Goodfield MJ; Rowell NR; Forster RA; Evans EG; Raven A
    Br J Dermatol; 1989 Dec; 121(6):753-7. PubMed ID: 2532927
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Terbinafine for onychomycosis.
    Med Lett Drugs Ther; 1996 Aug; 38(981):72-4. PubMed ID: 8699988
    [No Abstract]   [Full Text] [Related]  

  • 64. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine.
    Elewski BE
    Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581
    [No Abstract]   [Full Text] [Related]  

  • 65. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials.
    Krob AH; Fleischer AB; D'Agostino R; Feldman SR
    J Cutan Med Surg; 2003; 7(4):306-11. PubMed ID: 14738099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
    Ranawaka RR; Nagahawatte A; Gunasekara TA
    Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pustular psoriasiform eruption with leukocytosis associated with terbinafine.
    Papa CA; Miller OF
    J Am Acad Dermatol; 1998 Jul; 39(1):115-7. PubMed ID: 9674406
    [No Abstract]   [Full Text] [Related]  

  • 69. [Loss of taste sensation in terbinafine administration].
    Stricker BH; de Jong PA; Schreuder F; Bijlmer-Iest JC; Herrmann WA; van Ulsen J
    Ned Tijdschr Geneeskd; 1992 Dec; 136(49):2438-40. PubMed ID: 1470246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 74. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Terbinafine-induced generalized pustular psoriasis in a patient carrying CARD14 mutation.
    Sakai H; Nomura W; Fukushima H; Sugiura K; Iizuka H
    J Dermatol; 2019 Mar; 46(3):e110-e112. PubMed ID: 30144153
    [No Abstract]   [Full Text] [Related]  

  • 76. Terbinafine-induced cholestatic liver disease.
    Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
    J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
    Evans EG; Sigurgeirsson B
    BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.